Apogee Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Apogee Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Apogee Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apogee Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $50M | 595k | 84.17 |
| 2025-12-31 | $67M | 890k | 75.50 |
| 2025-09-30 | $19M | 465k | 39.73 |
| 2025-06-30 | $21M | 475k | 43.43 |
| 2024-12-31 | $9.5M | 210k | 45.30 |
| 2024-09-30 | $14M | 238k | 58.73 |
| 2024-06-30 | $9.2M | 235k | 39.35 |
| 2024-03-31 | $9.0M | 136k | 66.45 |
| 2023-12-31 | $1.9M | 68k | 27.94 |
| 2023-09-30 | $671k | 32k | 21.30 |